DIA480.51+0.71 0.15%
SPX6,774.76+53.33 0.79%
IXIC23,006.36+313.04 1.38%

12 Health Care Stocks Moving In Thursday's Pre-Market Session

Benzinga·12/18/2025 12:05:44
Listen to the news

Gainers

  • Athira Pharma (NASDAQ:ATHA) stock increased by 30.6% to $5.4 during Thursday's pre-market session. The market value of their outstanding shares is at $16.3 million.
  • Akanda (NASDAQ:AKAN) shares increased by 16.16% to $0.86.
  • Aligos Therapeutics (NASDAQ:ALGS) stock moved upwards by 12.32% to $11.94. The company's market cap stands at $65.4 million.
  • Ensysce Biosciences (NASDAQ:ENSC) stock rose 9.73% to $1.24. The company's market cap stands at $4.0 million.
  • PDS Biotechnology (NASDAQ:PDSB) shares increased by 9.71% to $0.95. The market value of their outstanding shares is at $47.3 million.
  • IM Cannabis (NASDAQ:IMCC) shares moved upwards by 7.95% to $1.9. The market value of their outstanding shares is at $9.2 million.

Losers

  • Insmed (NASDAQ:INSM) stock declined by 20.0% to $158.83 during Thursday's pre-market session. The company's market cap stands at $42.3 billion.
  • Pyxis Oncology (NASDAQ:PYXS) stock fell 15.14% to $2.86. The company's market cap stands at $209.8 million.
  • AlphaTON Capital (NASDAQ:ATON) stock declined by 13.36% to $0.79. The company's market cap stands at $7.4 million.
  • Biodexa Pharmaceuticals (NASDAQ:BDRX) shares declined by 12.46% to $4.78. The market value of their outstanding shares is at $3.3 million.
  • Aditxt (NASDAQ:ADTX) stock declined by 11.5% to $1.54. The company's market cap stands at $3.0 million.
  • AEON Biopharma (AMEX:AEON) stock declined by 8.27% to $0.89. The market value of their outstanding shares is at $13.3 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Contact Us

Contact Number : +852 3852 8500
Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email : service@webull.hk
Online Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation : marketinghk@webull.hk
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language

English

©2025 Webull Securities Limited. All rights reserved.